Your current location is:Fxscam News > Exchange Traders
Bitcoin heads toward $70,000, fueled by global monetary easing.
Fxscam News2025-07-23 15:54:10【Exchange Traders】6People have watched
IntroductionForeign exchange trading platform handling fee,Ranking of China foreign exchange platforms,Boosted by global loose monetary policies, Bitcoin is experiencing a new wave of growth. A recent re
Boosted by global loose monetary policies,Foreign exchange trading platform handling fee Bitcoin is experiencing a new wave of growth. A recent report from 10X Research predicts that, influenced by the Federal Reserve's rate cuts and China's large-scale quantitative easing policies, Bitcoin prices are likely to break through $70,000 and set new highs by the end of October.
Over the past month, the price of Bitcoin (BTC) has increased by more than 10% and is now stable above $65,000, up over 30% from the previous local low of $49,000. This strong momentum has significantly boosted market confidence, with analysts optimistic about its long-term development prospects.
Bitcoin's current market price is higher than the average realized value over the past year, indicating growing confidence among long-term investors and suggesting a more permanent uptrend.
The latest report from 10X Research further analyzes Bitcoin's market outlook. The report indicates that Bitcoin has successfully reversed its previous downward trend and is moving towards the $70,000 mark, with expectations to surpass this level within two weeks. As the end of October approaches, the market anticipates Bitcoin will reach new historical highs.
In addition to the Federal Reserve's rate cut cycle, 10X Research also emphasizes that China's loose policies will increase global liquidity, leading to a parabolic price rise in the cryptocurrency market. Previously, Bitcoin had once surged above $73,000 following events like the halving event, Trump's support, and the listing of Bitcoin ETFs. This time, it may be gearing up for another wave of growth.
Risk Warning and DisclaimerThe market carries risks, and investment should be cautious. This article does not constitute personal investment advice and has not taken into account individual users' specific investment goals, financial situations, or needs. Users should consider whether any opinions, viewpoints, or conclusions in this article are suitable for their particular circumstances. Investing based on this is at one's own responsibility.
Very good!(76467)
Related articles
- Market Insights: Mar 15th, 2024
- Shimao Group announces Hong Kong court agreed to delay liquidation to July 31.
- Blackstone to sell Japanese pharma company Alinamin to MBK for 350 billion yen
- Pepsi agrees to waive certain terms with Britvic to facilitate Carlsberg's acquisition.
- Yellow Corp files for bankruptcy amid union disputes, risking US taxpayer losses.
- London Metal Exchange plans to build a warehouse in Hong Kong to strengthen global logistics.
- Novo Nordisk faces competition as patents for diabetes, weight loss drugs expire in China.
- Optimistic rate cut expectations drive oil price rebound, ending continuous decline.
- Is Hankotrade compliant? How is its security?
- Hong Kong court delays Kaisa liquidation hearing, two months reprieve granted
Popular Articles
- EC Markets: Sharing Prosperity, Brand Ambassador Trump Triumphs at 2024 Snooker World Open.
- Hamilton Investment Management's sixth funding round succeeds, exceeding target by $600M.
- TSMC benefits from surging AI demand, valuation skyrockets in a year
- WestJet says union cancels strike, agrees to renegotiate, working to resume operations
Webmaster recommended
CP MARKETS Review: Regulated
Media reports EU to impose 25% extra tariff on Chinese EV imports starting next month
Even at the cost of reducing aircraft production, Airbus invests 900M in space projects.
Even at the cost of reducing aircraft production, Airbus invests 900M in space projects.
U.S. Treasury yields hit a multi
Fuji Film Japan surges due to TikTok boom, becoming top profit contributor.
Novo Nordisk faces competition as patents for diabetes, weight loss drugs expire in China.
Even at the cost of reducing aircraft production, Airbus invests 900M in space projects.